STOCK TITAN

MDJM (UOKA) seeks big capital increase and 2:1–200:1 share consolidation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

MDJM LTD has called an extraordinary general meeting on April 21, 2026 to seek shareholder approval for a major increase in authorized share capital and a flexible share consolidation.

The company proposes raising authorized capital from US$250,000,000, divided into 285,714,286 ordinary shares of par value US$0.875 each, to US$4,462,500,000, divided into 5,100,000,000 ordinary shares of the same par value. This would create 4,714,297,371 additional authorized Class A shares and 99,988,343 additional authorized Class B shares.

A second proposal would authorize the board, during a defined Relevant Period, to implement a share consolidation of all authorized and issued shares at a ratio between 2:1 and 200:1, leaving relative ownership largely unchanged except for rounding up fractional shares. The company explains that the consolidation is intended to help regain compliance with Nasdaq’s $1.00 minimum bid price requirement after its Class A shares were suspended from Nasdaq and moved to OTC trading following a period with a $0.10 or less closing bid price.

Positive

  • None.

Negative

  • None.

Insights

MDJM seeks flexible reverse split and large capital increase after Nasdaq suspension, but no specific issuance yet.

MDJM LTD is asking shareholders to approve two powerful tools: a large increase in authorized share capital and a broad mandate for a share consolidation of between 2:1 and 200:1. Authorized capital would rise from US$250,000,000 (285.7 million ordinary shares) to US$4,462,500,000 (5.1 billion ordinary shares).

The company links the consolidation proposal directly to Nasdaq’s $1.00 minimum bid price requirement, noting its Class A shares were suspended after trading at or below $0.10 for 10 consecutive business days and moved to OTC trading under “UOKAF”. A reverse split can mechanically raise the share price, which may support efforts to regain listing if Nasdaq grants relief.

The share consolidation will apply uniformly to all authorized, issued, and outstanding shares, with fractional positions rounded up to the next whole share and no cash paid. The large expansion in authorized Class A and Class B shares creates capacity for substantial future issuance, but this filing does not specify any concrete offering, timing, or use of those additional shares. The net impact on existing holders will depend on whether, and how aggressively, the new authorization is used after the meeting.

Current authorized share capital US$250,000,000 Divided into 285,714,286 ordinary shares of US$0.875 par value
Proposed authorized share capital US$4,462,500,000 Divided into 5,100,000,000 ordinary shares of US$0.875 par value
Proposed authorized Class A shares 5,000,000,000 shares Class A ordinary shares of US$0.875 par value each after increase
Proposed authorized Class B shares 100,000,000 shares Class B ordinary shares of US$0.875 par value each after increase
Share consolidation ratio range 2:1 to 200:1 Board-authorized consolidation of all authorized and issued shares
Nasdaq minimum bid requirement US$1.00 per share Listing maintenance standard for Class A ordinary shares
Trigger for Nasdaq suspension US$0.10 or less for 10 days Class A ordinary shares closing bid price threshold before suspension
Record date for voting March 27, 2026 Determines shareholders entitled to notice and vote at the meeting
extraordinary general meeting financial
"NOTICE IS HEREBY GIVEN THAT the extraordinary general meeting of shareholders"
share consolidation financial
"to effect a consolidation of the share capital of the Company (the “Share Consolidation”)"
Share consolidation is a process where a company reduces the total number of its shares by combining multiple existing shares into a smaller number of higher-value shares. This can make each share more expensive and potentially improve the company’s image. For investors, it often means their ownership remains the same, but the value of each share increases, which can influence how the stock is perceived and traded.
Minimum Bid Requirement financial
"minimum closing bid price of at least $1.00 per share (the “Minimum Bid Requirement”)"
penny stock financial
"a determination that the Company’s Class A Ordinary Share is a “penny stock,”"
fractional shares financial
"No fractional shares will be issued in connection with the Share Consolidation."
Fractional shares are portions of a whole share of a stock or fund, allowing investors to own less than one full unit. They make it possible to invest a specific dollar amount rather than buy whole shares, like buying a slice of a pizza instead of the entire pie. For investors this lowers the cost barrier, helps with diversification, and lets you reinvest dividends or purchase expensive stocks in small, precise amounts.
authorized share capital financial
"The Board of Directors proposes to increase its authorized share capital from US$250,000,000"
The maximum number of shares a company is legally allowed to issue according to its governing documents. Think of it as the size of the blank checkbook a company keeps for selling ownership stakes: it sets an upper limit but does not mean all shares are in circulation. Investors care because a larger authorized amount makes it easier for the company to raise money or grant stock-based pay, which can dilute existing holdings and affect control and value per share.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2026

 

Commission File Number: 001-38768

 

MDJM LTD

 

Fernie Castle, Letham 

Cupar, Fife, KY15 7RU 

United Kingdom 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x   Form 40-F ¨

 

 

 

 

EXPLANATORY NOTE

 

In connection with an extraordinary general meeting of shareholders (the “Meeting”) of MDJM LTD, a Cayman Islands company (the “Company”), the Company hereby furnishes the notice and proxy statement of the Meeting and the form of proxy card as Exhibits 99.1 and 99.2, respectively.

 

Exhibits

 

Exhibit No.   Description
99.1   Notice and Proxy Statement of the Meeting, dated March 31, 2026, to be mailed to the shareholders of the Company in connection with the Meeting
99.2   Form of Proxy Card to be mailed to shareholders of the Company for use in connection with the Meeting

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MDJM LTD
   
  By: /s/ Siping Xu
    Siping Xu
    Chief Executive Officer

 

Date: March 31, 2026

 

 

Exhibit 99.1

 

MDJM LTD

 

(incorporated in the Cayman Islands with limited liability)

 

(OTCID: UOKAF)

 

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 

NOTICE IS HEREBY GIVEN THAT the extraordinary general meeting of shareholders (the “Meeting”) of MDJM LTD (the “Company”) will be held on April 21, 2026, at 11:30 am Eastern Time, at Fernie Castle, Letham, Cupar, Fife, KY15 7RU, United Kingdom, for the following purposes:

 

1 To increase the authorized share capital of the Company:

FROM: US$250,000,000 divided into 285,714,286 ordinary shares of par value US$0.875 each, consisting of (a) 285,702,629 Class A Ordinary Shares of par value US$0.875 each and (b) 11,657 Class B Ordinary Shares of par value US$0.875 each.

TO: US$4,462,500,000 divided into 5,100,000,000 ordinary shares of par value US$0.875 each, consisting of (a) 5,000,000,000 Class A Ordinary Shares of par value US$0.875 each and (b) 100,000,000 Class B Ordinary Shares of par value US$0.875 each, by the creation of 4,714,297,371 authorised and unissued Class A Ordinary Shares and 99,988,343 authorised and unissued Class B Ordinary Shares.  

 

2

To pass an ordinary resolution that the Company grants a mandate to the board of directors of the Company (the Board) during the Relevant Period (as defined below) to effect a consolidation of the share capital of the Company (the Share Consolidation), including all issued ordinary shares and any unissued ordinary shares, at the consolidation ratio and effective time as the Board may determine at their sole discretion, provided that the consolidation ratio resulting from the Share Consolidation effected pursuant to this mandate shall be not less than 2:1 and not more than 200:1 (the Consolidation Ratio), with such consolidated shares having the same rights and being subject to the same restrictions as set out in the Articles, be and is hereby generally and unconditionally approved.

For the purpose of the Share Consolidation, Relevant Period means the period from the date of passing of the resolution of the Meeting until whichever is the earliest of:

 

(i)             the first time the Board has exercised the power to give effect to the Share Consolidation; or

 

(ii)            the date on which such mandate granted under the resolution of the Meeting is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.  

   
  The Company authorises the Board during the Relevant Period to take such actions to give effect to the Share Consolidation that would or might require the exercise of the aforesaid powers during or after the end of the Relevant Period, and shall include and without limitation, the determination of the Consolidation Ratio for the Class A Ordinary Shares and the Class B Ordinary Shares.

 

The board of directors of the Company (the “Board of Directors”) has fixed the close of business on March 27, 2026 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of and to vote at the Meeting or any adjournment thereof. Subject to the provisions of the memorandum and articles of association (as amended) of the Company and to any restrictions imposed on any shares, only holders of ordinary shares of the Company on the Record Date are entitled to receive notice of and to vote at the Meeting or any adjournment thereof.

 

 

Shareholders may obtain a copy of the proxy materials, including the Company’s 2024 annual report, by submitting a request to ir@mdjmjh.com.

 

By Order of the Board of Directors,  
   
/s/ Siping Xu  
Siping Xu  
Chairman of the Board of Directors  

 

March 31, 2026

 

 

MDJM LTD

 

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 

April 21, 2026

 

11:30 am Eastern Time

 

PROXY STATEMENT

 

The board of directors (the “Board of Directors”) of MDJM LTD (the “Company”) is soliciting proxies for the extraordinary general meeting of shareholders (the “Meeting”) of the Company to be held on April 21, 2026, at 11:30 am Eastern Time, at Fernie Castle, Letham, Cupar, Fife, KY15 7RU, United Kingdom or any adjournment thereof.

 

Only holders of the ordinary shares of the Company of record at the close of business on March 27, 2026 (the “Record Date”) are entitled to attend and vote at the Meeting or at any adjournment thereof. The shareholders entitled to vote and present, in person or by proxy or (in the case of a shareholder being a corporate entity) by its duly authorized representative, representing not less than one-third in nominal value of the total issued voting shares in the Company throughout the meeting shall form a quorum.

 

Any shareholder entitled to attend and vote at the Meeting is entitled to appoint a proxy to attend and vote on such shareholder’s behalf. A proxy need not be a shareholder of the Company. Each holder of the Company’s Class A ordinary shares shall be entitled to one vote in respect of each Class A ordinary share held by such holder on the Record Date. Each holder of the Company’s Class B ordinary shares shall be entitled to 50 votes in respect of each Class B ordinary share held by such holder on the Record Date.

 

PROPOSALS TO BE VOTED ON

 

At the Meeting, ordinary resolutions will be proposed as follows:

 

1 to increase the authorized share capital of the Company:

FROM: US$250,000,000 divided into 285,714,286 ordinary shares of par value US$0.875 each, consisting of (a) 285,702,629 Class A ordinary shares of par value US$0.875 each and (b) 11,657 Class B ordinary shares of par value US$0.875 each.

TO: US$4,462,500,000 divided into 5,100,000,000 ordinary shares of par value US$0.875 each, consisting of (a) 5,000,000,000 Class A ordinary shares of par value US$0.875 each and (b) 100,000,000 Class B ordinary shares of par value US$0.875 each, by the creation of 4,714,297,371 authorised and unissued Class A Ordinary Shares and 99,988,343 authorised and unissued Class B Ordinary Shares.  

 

2 the Company grants a mandate to the board of directors of the Company (the Board) during the Relevant Period (as defined below) to effect a consolidation of the share capital of the Company (the Share Consolidation), including all issued ordinary shares and any unissued ordinary shares, at the consolidation ratio and effective time as the Board may determine at their sole discretion, provided that the consolidation ratio resulting from the Share Consolidation effected pursuant to this mandate shall be not less than 2:1 and not more than 200:1 (the Consolidation Ratio), with such consolidated shares having the same rights and being subject to the same restrictions as set out in the Articles, be and is hereby generally and unconditionally approved.

 

 

 

For the purpose of the Share Consolidation, Relevant Period means the period from the date of passing of the resolution of the Meeting until whichever is the earliest of:

 

(i)           the first time the Board has exercised the power to give effect to the Share Consolidation; or

 

(ii)           the date on which such mandate granted under the resolution of the Meeting is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.

 

The Company authorises the Board during the Relevant Period to take such actions to give effect to the Share Consolidation that would or might require the exercise of the aforesaid powers during or after the end of the Relevant Period, and shall include and without limitation, the determination of the Consolidation Ratio for the Class A Ordinary Shares and the Class B Ordinary Shares.

 

The Board of Directors recommends a vote “FOR” each of the Proposals.

 

VOTING PROCEDURE FOR HOLDERS OF ORDINARY SHARES

 

Shareholders entitled to vote at the Meeting may do so either in person or by proxy. Those shareholders who are unable to attend the Meeting are requested to read, complete, sign, date, and return the attached proxy card in accordance with the instructions set out therein.

 

ANNUAL REPORT TO SHAREHOLDERS

 

Pursuant to NASDAQ’s Marketplace Rules that permit companies to make available their annual report to shareholders on or through the company’s website, the Company posts its annual reports on the Company’s website. The annual report for the year ended December 31, 2024 (the “2024 Annual Report”) has been filed with the U.S. Securities and Exchange Commission. The Company adopted this practice to avoid the considerable expense associated with mailing physical copies of such report to record holders. If you want to receive a paper or email copy of the Company’s 2024 Annual Report to shareholders, you must request one. There is no charge to you for requesting a copy. Please make your request for a copy to the Investor Relations department of the Company, at ir@mdjmjh.com

 

 

PROPOSAL NO. 1 

 

THE INCREASE OF SHARE CAPITAL

 

The Board of Directors proposes to increase its authorized share capital from US$250,000,000 divided into 285,714,286 ordinary shares of par value US$0.875 each, consisting of (a) 285,702,629 Class A ordinary shares of par value US$0.875 each and (b) 11,657 Class B ordinary shares of par value US$0.875 each, to US$4,462,500,000 divided into 5,100,000,000 ordinary shares of par value US$0.875 each, consisting of (a) 5,000,000,000 Class A ordinary shares of par value US$0.875 each and (b) 100,000,000 Class B ordinary shares of par value US$0.875 each, by the creation of 4,714,297,371 authorised and unissued Class A Ordinary Shares and 99,988,343 authorised and unissued Class B Ordinary Shares.

 

RESOLUTION TO BE VOTED UPON

 

The full text of the resolution to be proposed is as follows:

 

RESOLVED, as an ordinary resolution of Shareholders that, with effect from 11:30 a.m. (Eastern Time) on April 21, 2026:

 

  to increase the authorized share capital of the Company:
   
 

FROM: US$250,000,000 divided into 285,714,286 ordinary shares of par value US$0.875 each, consisting of (a) 285,702,629 Class A ordinary shares of par value US$0.875 each and (b) 11,657 Class B ordinary shares of par value US$0.875 each.

 

TO: US$4,462,500,000 divided into 5,100,000,000 ordinary shares of par value US$0.875 each, consisting of (a) 5,000,000,000 Class A ordinary shares of par value US$0.875 each and (b) 100,000,000 Class B ordinary shares of par value US$0.875 each,

 

by the creation of 4,714,297,371 authorised and unissued Class A Ordinary Shares and 99,988,343 authorised and unissued Class B Ordinary Shares.

 

VOTE REQUIRED FOR APPROVAL

 

The approval of Proposal No. 1 requires an ordinary resolution under Cayman Islands law, being the affirmative vote of at least a simple majority of the votes cast at the Meeting by shareholders who, being present and entitled to vote in person at the Meeting, vote in person or, where proxies are allowed, by proxy or, in the case of corporations, by their duly authorized representatives.

 

Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as a vote cast at the Meeting.

 

THE BOARD OF DIRECTORS RECOMMENDS

 

A VOTE FOR

 

THE INCREASE OF SHARE CAPITAL.

 

 

PROPOSAL NO. 2 

 

APPROVAL OF A SHARE CONSOLIDATION, SUBJECT TO THE DETERMINATION OF THE CONSOLIDATION RATIO AND TIMING BY THE BOARD OF DIRECTORS

 

General

 

The Board of Directors believes that it is in the best interest of the Company and the shareholders, and is hereby soliciting shareholder approval, to effect a share consolidation of the Company’s authorized and issued shares (the “Share Consolidation”), at a consolidation ratio from such Share Consolidation ranging from not less than 2:1 and not greater than 200:1, at the reasonable discretion of the Board of Directors. 

 

The Share Consolidation must be passed by an ordinary resolution which requires the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy or, in the case of corporations, by their duly authorized representative, at the Meeting. If the Company’s shareholders approve this proposal, the Board of Directors will have authority to implement the Share Consolidation at any time after the approval of the Share Consolidation.

 

The Share Consolidation will be implemented simultaneously for all authorized, issued, and outstanding shares. The Share Consolidation will affect all shareholders uniformly and will have no effect on the proportionate holdings of any individual shareholder, with the exception of adjustments related to the treatment of fractional shares (see below under the subheading “Fractional Shares”).

 

Purpose of the Share Consolidation

 

On March 13, 2026, the Company received a staff determination letter from the Listing Qualifications Department of Nasdaq, notifying that the Company’s Class A ordinary shares would be suspended from trading on Nasdaq, effective with the open of trading on March 20, 2026, as a result of the Company’s Class A ordinary shares having a closing bid price of $0.10 or less for 10 consecutive business days.

 

On March 20, 2026, the Company’s Class A ordinary shares were suspended from trading on Nasdaq and commenced trading on the OTCID Basic Markets under the ticker symbol “UOKAF.” On the same day, the Company submitted a hearing request to an independent Nasdaq Hearing Panel to appeal the suspension determination. However, the outcome of the hearing remains uncertain. Should the hearing result in an unfavorable determination, Nasdaq may file a Form 25-NSE with the U.S. Securities and Exchange Commission to delist and remove the Company’s Class A ordinary shares from the Nasdaq Capital Market.

 

The suspension and potential delisting of the Company’s Class A ordinary shares from Nasdaq and the trading on OTCID Basic Markets have had, and may continue to have, material adverse effects on the Company’s business and its shareholders, including a limited availability for market quotations and reduced liquidity with respect to its Class A ordinary shares; a determination that the Company’s Class A Ordinary Share is a “penny stock,” which will require brokers trading in its Class A Ordinary Share to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for the Company’s Class A Ordinary Share; limited amount of news and analyst coverage; and a decreased ability to issue additional securities or obtain additional financing in the future.

 

Among other requirements, the listing maintenance standards established by Nasdaq require the Class A ordinary shares to have a minimum closing bid price of at least $1.00 per share (the “Minimum Bid Requirement”). To ensure the Company to regain compliance with the Minimum Bid Requirement, the Board of Directors determined that it was in the best interest of the Company and its shareholders to solicit the approval of the Shareholders for the Share Consolidation.

 

 

Registration and Trading of the Company’s Class A Ordinary Shares

 

The Share Consolidation will not affect the registration of the Company’s Class A ordinary shares or the Company’s obligation to publicly file financial and other information with the U.S. Securities and Exchange Commission. When the Share Consolidation is implemented, the Company’s Class A ordinary shares will begin trading on a post-consolidation basis on the effective date that the Company announces such implementation by press release or a Form 6-K. In connection with the Share Consolidation, the CUSIP number of the Company’s Class A ordinary shares (which is an identifier used by participants in the securities industry to identify the Company’s Class A ordinary shares) will change.

 

Fractional Shares

 

No fractional shares will be issued in connection with the Share Consolidation. Instead, record holders who otherwise would be entitled to receive fractional shares because they hold a number of shares not evenly divisible by the Share Consolidation ratio will automatically be entitled to receive an additional fraction of one share of the relevant class to round up to the next whole share. For those beneficial holders who hold shares through a brokerage firm, the Company intends to round up fractional shares at the participant level. Cash will not be paid for fractional shares. 

 

Authorized Shares

 

At the time the Share Consolidation is effective, the Company’s authorized shares will be consolidated at the same ratio, meaning there will be a reduction in the number of the authorized shares in the Company by a factor determined by the board of directors.

 

Street Name Holders of Class A Ordinary Shares

 

The Company intends for the Share Consolidation to treat shareholders holding Class A ordinary shares in street name through a nominee (such as a bank or broker) in the same manner as shareholders whose shares are registered in their names. Nominees will be instructed to effect the Share Consolidation for their beneficial holders. However, nominees may have different procedures. Accordingly, shareholders holding Class A ordinary shares in street name should contact their nominees.

 

Share Certificates

 

Mandatory surrender of certificates is not required by the Company’s shareholders. The Company’s transfer agent will adjust the record books of the Company to reflect the Share Consolidation as of the effective date. New certificates will not be mailed to shareholders.

 

 

RESOLUTION TO BE VOTED UPON

 

The full text of the resolution to be proposed is as follows:

 

RESOLVED, as an ordinary resolution of Shareholders that, with effect from 11:30 a.m. (Eastern Time) on April 21, 2026: 

 

 

the Company grants a mandate to the board of directors of the Company (the Board) during the Relevant Period (as defined below) to effect a consolidation of the share capital of the Company (the “Share Consolidation”), including all issued ordinary shares and any unissued ordinary shares, at the consolidation ratio and effective time as the Board may determine at their sole discretion, provided that the consolidation ratio resulting from the Share Consolidation effected pursuant to this mandate shall be not less than 2:1 and not more than 200:1 (the Consolidation Ratio), with such consolidated shares having the same rights and being subject to the same restrictions as set out in the Articles, be and is hereby generally and unconditionally approved.

 

For the purpose of the Share Consolidation, Relevant Period means the period from the date of passing of the resolution of the Meeting until whichever is the earliest of:

 

(i)              the first time the Board has exercised the power to give effect to the Share Consolidation; or

 

(ii)            the date on which such mandate granted under the resolution of the Meeting is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.

 

  The Company authorises the Board during the Relevant Period to take such actions to give effect to the Share Consolidation that would or might require the exercise of the aforesaid powers during or after the end of the Relevant Period, and shall include and without limitation, the determination of the Consolidation Ratio for the Class A Ordinary Shares and the Class B Ordinary Shares.

 

VOTE REQUIRED FOR APPROVAL

 

The approval of Proposal No. 2 requires an ordinary resolution under Cayman Islands law, being the affirmative vote of at least a simple majority of the votes cast at the Meeting by shareholders who, being present and entitled to vote in person at the Meeting, vote in person or, where proxies are allowed, by proxy or, in the case of corporations, by their duly authorized representatives.

 

Abstentions and broker non-votes, while considered present for the purposes of establishing a quorum, will not count as a vote cast at the Meeting.

 

THE BOARD OF DIRECTORS RECOMMENDS

 

A VOTE FOR

 

THE SHARE CONSOLIDATION.

 

 

 

OTHER MATTERS

 

The Board of Directors is not aware of any other matters to be submitted to the Meeting. If any other matters properly come before the Meeting, it is the intention of the persons named in the enclosed form of proxy to vote the shares they represent as the Board of Directors may recommend.

 

 

 

March 31, 2026 By order of the Board of Directors
   
  /s/ Siping Xu
  Siping Xu
  Chairman of the Board of Directors

 

 

 

Exhibit 99.2

 

Important Notice Regarding the Availability of Proxy Materials for the Extraordinary General Meeting:

 

MDJM LTD
Extraordinary General Meeting of Shareholders
21 April 2026
11:30 a.m. Eastern Time
 
THIS PROXY IS SOLICITED ON BEHALF OF
THE BOARD OF DIRECTORS OF MDJM LTD
 
The undersigned shareholder of MDJM LTD, a Cayman Islands company (the “Company”), hereby acknowledges receipt of the Notice of Extraordinary General Meeting of the Shareholders (the “Meeting”) and the Proxy Statement, each dated 31 March 2026, and hereby appoints, if no person is specified, the chairman of the Meeting, as proxy, with full power of substitution, on behalf and in the name of the undersigned, to represent the undersigned at the Meeting to be held on 21 April 2026, at 11:30 a.m. Eastern Time, at Fernie Castle, Letham, Cupar, Fife, KY15 7RU, United Kingdom, or at any adjournment or postponement thereof, and to vote all ordinary shares which the undersigned would be entitled to vote if then and there personally present, on the matters set forth below (i) as specified by the undersigned below and (ii) in the discretion of any proxy upon such other business as may properly come before the Meeting, all as set forth in the Notice of the Meeting and in the Proxy Statement furnished herewith.
 
This proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this proxy will be voted “FOR” Proposal No.1 and in the discretion of the proxy with respect to such other business as may properly come before the meeting. 
 
Continued and to be signed

 

VOTE BY INTERNET

 

www.Transhare.com (click on Vote Your Proxy and enter your control number)

 

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m., Eastern Time, 20 April 2026. Have your proxy card in hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form.

 

VOTE BY EMAIL

 

Please email your signed proxy card to Proxy@Transhare.com.

 

VOTE BY FAX

 

Please fax your signed proxy card to +1.727.269.5616.

 

VOTE BY MAIL

 

Please sign, date and mail to Proxy Team, Transhare Corporation, 17755 US Highway 19 N, Suite 140, Clearwater FL 33764.

 

 

 

 

ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS

 

If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards, and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please provide your email address below and check here to indicate your consent to receive or access proxy materials electronically in future years.

 

Email Address:    

 

 

 

 

THIS PROXY CARD

 

Please read the explanatory notes overleaf before the completing this form.

 

I/We, ____________________, being a member of the Company, appoint the Chairman of the meeting /NAME OF PROXY as my/our proxy to attend, speak and vote on my/our behalf at the Extraordinary General Meeting of the Company to be held on 21 April 2026 at 11:30 a.m. Eastern Time and at any adjournment of the meeting.

 

If you wish to appoint multiple proxies, please see note 1 overleaf. If you are appointing more than one proxy, please indicate each of the proxy in the box below and complete the number of shares in relation to which they are authorised to act as proxy. Otherwise, this section can be left blank.

 

PROXY NAME NUMBER OF SHARES
   

 

The proxy is to vote on the following resolution as I/we have instructed by making the appropriate box with an “X”.

 

The Board of Directors recommends voting FOR the following:

 

    FOR AGAINST ABSTAIN
Proposal No. 1

the authorised share capital of the Company be increased:

 

FROM: US$250,000,000 divided into 285,714,286 ordinary shares of US$0.875 par value each, consisting of (a) 285,702,629 Class A Ordinary Shares and (b) 11,657 Class B Ordinary Shares,

 

TO: US$4,462,500,000 divided into 5,100,000,000 ordinary shares of US$0.875 par value each, consisting of (a) 5,000,000,000 Class A Ordinary Shares and (b) 100,000,000 Class B Ordinary Shares,

 

by the creation of 4,714,297,371 authorised and unissued Class A Ordinary Shares and 99,988,343 authorised and unissued Class B Ordinary Shares.

¨ ¨ ¨

 

 

 

 

Proposal No. 2

(a)         the Company grants a mandate to the board of directors of the Company (the Board) during the Relevant Period (as defined below) to effect a consolidation of the share capital of the Company (the Share Consolidation), including all issued ordinary shares and any unissued ordinary shares, at the consolidation ratio and effective time as the Board may determine at their sole discretion, provided that the consolidation ratio resulting from the Share Consolidation effected pursuant to this mandate shall be not less than 2:1 and not more than 200:1 (the Consolidation Ratio), with such consolidated shares having the same rights and being subject to the same restrictions as set out in the Articles, be and is hereby generally and unconditionally approved;

 

(b)         for the purpose of this resolution, Relevant Period means the period from the date of passing of this resolution until whichever is the earliest of:

 

(i)    the first time the Board has exercised the power to give effect to the Share Consolidation; or

 

(ii)   the date on which such mandate granted under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting; and

 

(c)         authorise the Board during the Relevant Period to take such actions to give effect to the Share Consolidation that would or might require the exercise of the aforesaid powers during or after the end of the Relevant Period, and shall include and without limitation, the determination of the Consolidation Ratio for the Class A Ordinary Shares and the Class B Ordinary Shares.

¨ ¨ ¨

 

 

 

 

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If an entity, please sign in the full entity name, by a duly authorized officer.

 

   
   
Share Owner signs here
Co-Owner signs here
   
Date:  

 

Note:

 

1.As a member of the Company, you are entitled to appoint a proxy or proxies to exercise all or any of your rights to attend, speak and vote at a general meeting of the Company. You can only appoint a proxy using the procedures set out in these notes. If the proxy is being appointed in relation to part of your shares in relation to which they are authorised to act as your proxy. If this box is left blank, they will be authorised in respect of your full voting entitlement.

 

2.This form of proxy confers authority to demand or join in demanding a poll.

 

3.Appointment of a proxy does not preclude you from attending the meeting and voting in person. If you have appointed a proxy and attend the meeting in person, your proxy appointment will automatically be terminated.

 

4.A proxy does not need to be a member of the Company but must attend the meeting to represent you. If you wish to appoint a proxy other than the chairman of the meeting, insert their full name in the box. If you leave this space blank, the chairman of the meeting will be appointed your proxy. Where you appoint as your proxy someone other than the chairman, you are responsible for ensuring that they attend the meeting and are aware of your voting intentions. If you wish your proxy to make any comments on your behalf, you will need to appoint someone other than the chairman and give them the relevant instruments directly.

 

5.You may appoint more than one proxy provided each proxy is appointed to exercise rights attached to different shares. You may not appoint more than one proxy to exercise rights attached to any one share. To appoint more than one proxy, you may copy this form. If you are appointing more than one proxy, please indicate in the box next to the proxy holder’s name the number of shares in relation to which they are authorised to act as your proxy and indicate by ticking the relevant box that the proxy appointment is one of multiple appointments being made. Multiple appointments should be returned together in the same envelope.

 

6.In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company’s register of members in respect of the joint holding (the first-named being the most senior).

 

7.To direct your proxy how to vote on the resolutions mark the appropriate box with an “X”. If no voting indication is given, your proxy will vote or abstain from voting at his or her discretion. Your proxy will vote (or abstain from voting) as he or she thinks fit in relation to any other matter which is put before the meeting, including a motion to adjourn.

 

8.To validity appoint a proxy using this form, the form must be:

 

a.Completed and signed. Where the appointer is a corporation then the form must be executed under the hand of an officer duly authorised to do so;

 

b.Sent and delivered in accordance with the methods set forth in the proxy form; and

 

c.Received by the Company no later than forty-eight hours before the time set for the meeting.

 

9.If you submit more than one valid proxy appointment, the appointment received last before the latest time for the receipt of proxies will take precedence.

 

 

 

FAQ

What is MDJM (UOKA) asking shareholders to approve at the April 21, 2026 meeting?

MDJM is seeking approval to significantly increase its authorized share capital and to give its board discretion to implement a share consolidation between 2:1 and 200:1. Both proposals require a simple majority of votes cast by shareholders present or represented by proxy.

How much will MDJM (UOKA) increase its authorized share capital if Proposal No. 1 passes?

Authorized share capital would rise from US$250,000,000, divided into 285,714,286 ordinary shares of US$0.875 par value, to US$4,462,500,000, divided into 5,100,000,000 ordinary shares. This includes 5,000,000,000 Class A and 100,000,000 Class B ordinary shares after the increase.

What is the range of MDJM’s proposed share consolidation ratio in Proposal No. 2?

The share consolidation would allow MDJM’s board to choose a consolidation ratio between not less than 2:1 and not more than 200:1. It applies to all authorized, issued, and outstanding shares, with relative ownership preserved except for rounding of fractional shares.

Why is MDJM (UOKA) proposing a share consolidation of its ordinary shares?

MDJM links the consolidation to Nasdaq’s US$1.00 minimum bid price rule. Its Class A shares were suspended after closing at US$0.10 or less for 10 consecutive business days and moved to OTC trading, so a higher per-share price may support efforts to regain compliance.

How will MDJM handle fractional shares created by the share consolidation?

MDJM will not issue fractional shares or pay cash. Instead, any shareholder entitled to a fractional share will be rounded up to the next whole share, and for beneficial holders in street name, rounding is intended at the participant level through their intermediaries.

What voting power do MDJM Class A and Class B ordinary shares carry at the meeting?

Each Class A ordinary share entitles its holder to one vote, while each Class B ordinary share provides 50 votes. Only holders of record as of March 27, 2026, may vote in person, by proxy, or through an authorized representative at the extraordinary general meeting.

What quorum and approval threshold are required for MDJM’s 2026 extraordinary meeting proposals?

A quorum exists when shareholders representing at least one-third in nominal value of total issued voting shares are present or represented. Each proposal needs an ordinary resolution, meaning a simple majority of votes cast by shareholders entitled to vote and present in person or by proxy.

Filing Exhibits & Attachments

2 documents
MDJM LTD

NASDAQ:UOKA

View UOKA Stock Overview

UOKA Rankings

UOKA Latest News

UOKA Latest SEC Filings

UOKA Stock Data

18.05M
1.03M
Lodging
Consumer Cyclical
Link
United Kingdom
Cupar